1) The document describes several metabolic pathways involving cholesterol, bile acids, and steroid hormone synthesis.
2) It shows the neutral and acidic pathways for cholesterol catabolism into bile acids and the primary and secondary bile acid synthesis pathways.
3) Several figures are presented outlining the roles of nuclear receptors like FXR, LXR, PXR, and VDR in regulating bile acid, cholesterol, and triglyceride metabolism in the liver, intestine, and kidneys.
4. FAS Triglyceride
activity synthesis
CAR PXR
FXR PPARα
Srebp-1c
β-Oxidation PPARα CTP-1
ApoC III CD36
VLDL Fas
ApoA V Acc-1 β-Oxidation
receptor
ApoC II Scd-1
Syndecan-1 human
lipogenesis
Increase LPL mouse
activity
A
Increase VLDL and CM B
clearance
Figure 4
5. hyperglicaemia
FXR Insulin resistance
GS GLUT4
G6Pase PK
PEPCK glycogen synthesis Insulin
F1,6bPase glycolisis signaling
FAs synthesis Inflammatory
cytokines SKELETAL MUSCLE
gluconegenesis
Glucose
production
Glucose uptake
LIVER
appetite
Insulin secretion
FXR
Adipocytes β cells protection
GLUT4 differentiation
Lipid GLP-1 GLP-1
TGR5
Inflammatory
storage
cytokines AC
GDP
WAT αβ
γ
P
PANCREAS c-AM GTP
α
Figure 5 GUT
7. Skeletal muscle
TGR5 AC T4
TR
T3
D2 1α
C-AMP PGC
2
P α β γ UCP
FXR
GD
P CRE
GT
α
Rα PK
PPA
Uncoupling
n FFA /
atio TRIGLYCERIDES B-oxidation
xid
Β-o Oxidative phosphorylation
large
adipocyte
TNF-α
IR T4 TR
AC T3
TGR5 P
D2 C1
PG P1
α
c-AM UC
FXR adiponectin P2
/3
γ UC
αβ
DP
G CRE
adipocytes
differentiation
leptin
P
GT α
CAR
BAT
WAT
pre-adipocyte
Figure 7